J L Harousseau

4.6k total citations · 1 hit paper
36 papers, 3.3k citations indexed

About

J L Harousseau is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, J L Harousseau has authored 36 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 11 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in J L Harousseau's work include Multiple Myeloma Research and Treatments (12 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Acute Myeloid Leukemia Research (7 papers). J L Harousseau is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Acute Myeloid Leukemia Research (7 papers). J L Harousseau collaborates with scholars based in France, Canada and Belgium. J L Harousseau's co-authors include Pierre Biron, Thierry Philip, Cesare Guglielmi, Bertrand Coiffier, Franck Chauvin, Pieter Sonneveld, Anton Hagenbeek, Jean‐Yves Cahn, Dominique Bron and F Mandelli and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

J L Harousseau

36 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

1995 1.8k citations Thierry Philip, Cesare Guglielmi et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J L Harousseau France	22	1.8k	1.8k	1.1k	815	590	36	3.3k
Réda Bouabdallah France	28	1.9k 1.1×	2.0k 1.1×	1.5k 1.3×	913 1.1×	600 1.0×	101	4.0k
Tak Takvorian United States	27	1.5k 0.9×	1.1k 0.6×	957 0.8×	899 1.1×	529 0.9×	58	2.9k
Alessandro Levis Italy	32	2.1k 1.2×	1.3k 0.7×	1.1k 1.0×	616 0.8×	819 1.4×	100	3.8k
Aspasia Stamatoullas France	34	1.7k 1.0×	1.3k 0.7×	1.4k 1.2×	1.2k 1.5×	449 0.8×	126	3.6k
Nicolas Ketterer Switzerland	23	2.8k 1.6×	2.5k 1.4×	1.1k 0.9×	1.4k 1.7×	658 1.1×	69	4.5k
Bertram Glaß Germany	26	2.4k 1.4×	2.2k 1.2×	922 0.8×	1000 1.2×	944 1.6×	102	4.1k
John P. Greer United States	31	1.5k 0.8×	1.3k 0.7×	914 0.8×	556 0.7×	379 0.6×	119	3.3k
B Desablens France	23	1.4k 0.8×	744 0.4×	854 0.7×	1.2k 1.5×	431 0.7×	89	2.6k
Marı́a Dolores Caballero Spain	32	1.4k 0.8×	1.2k 0.7×	1.1k 1.0×	586 0.7×	348 0.6×	74	2.8k
David S. Viswanatha United States	32	1.8k 1.0×	1.1k 0.6×	1.2k 1.0×	966 1.2×	362 0.6×	133	3.6k

Countries citing papers authored by J L Harousseau

Since Specialization

Citations

This map shows the geographic impact of J L Harousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J L Harousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J L Harousseau more than expected).

Fields of papers citing papers by J L Harousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J L Harousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J L Harousseau. The network helps show where J L Harousseau may publish in the future.

Co-authorship network of co-authors of J L Harousseau

This figure shows the co-authorship network connecting the top 25 collaborators of J L Harousseau. A scholar is included among the top collaborators of J L Harousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J L Harousseau. J L Harousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brissot, Éolia, Fanny Rialland, Xavier Cahu, et al.. (2015). Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution. Bone Marrow Transplantation. 51(2). 267–272. 30 indexed citations

Giorgi, Ugo De, Giovanni Rosti, S Slavin, et al.. (2005). Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours. British Journal of Cancer. 93(4). 412–417. 58 indexed citations

Puthier, Denis, et al.. (2001). Interferon α extends the survival of human myeloma cells through an upregulation of the Mcl‐1 anti‐apoptotic molecule. British Journal of Haematology. 112(2). 358–363. 45 indexed citations

Brice, Pauline, D. Simon, Réda Bouabdallah, et al.. (2000). High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol. Annals of Oncology. 11(12). 1585–1590. 68 indexed citations

Harousseau, J L. (1999). [Leukemias induced by anticancer chemotherapies].. PubMed. 86(11). 929–38. 3 indexed citations

Moreau, Philippe, et al.. (1999). [High-dose melphalan in patients with multiple myeloma].. PubMed. 86(3). 283–8. 1 indexed citations

Classe, Jean‐Marc, et al.. (1998). Ovarian transposition by laparoscopy before radiotherapy in the treatment of hodgkin's disease. Cancer. 83(7). 1420–1424. 22 indexed citations

Andrieu, Jean‐Marie, Jean-Philippe Jaı̈s, P Colonna, et al.. (1998). Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin’s disease at advanced stages. Annals of Oncology. 9(2). 195–203. 16 indexed citations

Hermouet, Sylvie, Danielle Pineau, Nelly Robillard, et al.. (1997). Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products. PubMed. 39(6). 317–325. 12 indexed citations

10.

Juge‐Morineau, Nadine, J L Harousseau, Martine Amiot, & Régis Bataille. (1997). The Retinoblastoma Susceptibility Gene RB-1 in Multiple Myeloma. Leukemia & lymphoma. 24(3-4). 229–237. 20 indexed citations

11.

Moreau, Philippe, D Fière, W. R. Bezwoda, et al.. (1997). Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.. Journal of Clinical Oncology. 15(2). 660–666. 34 indexed citations

12.

Solal-Céligny, P., Pauline Brice, Nicole Brousse, et al.. (1996). Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.. Journal of Clinical Oncology. 14(2). 514–519. 127 indexed citations

13.

Méchinaud, Françoise, et al.. (1996). [Thymus hyperplasia following chemotherapy].. PubMed. 25(7). 291–2. 3 indexed citations

14.

Mahé, Beatrice, Nöel Milpied, Sylvie Hermouet, et al.. (1996). G‐CSF alone mobilizes sufficient peripheral blood CD34⁺ cells for positive selection in newly diagnosed patients with myeloma and lymphoma. British Journal of Haematology. 92(2). 263–268. 39 indexed citations

15.

Kergueris, M. F., Nöel Milpied, Philippe Moreau, J L Harousseau, & C Larousse. (1995). Pharmacokinetics of high-dose melphalan in adults: influence of renal function.. PubMed. 14(6A). 2379–82. 31 indexed citations

16.

Philip, Thierry, Cesare Guglielmi, Anton Hagenbeek, et al.. (1995). Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma. New England Journal of Medicine. 333(23). 1540–1545. 1798 indexed citations breakdown →

17.

Mahé, Beatrice, et al.. (1994). Isolated Richter's syndrome of the brain: two recent cases.. PubMed. 36(5). 383–5. 19 indexed citations

18.

Quesnel, Bruno, H. Kantarjian, Elihu H. Estey, et al.. (1993). Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.. Journal of Clinical Oncology. 11(12). 2370–2379. 126 indexed citations

19.

Detourmignies, Laurence, Sylvie Castaigné, A. M. Stoppa, et al.. (1992). Therapy-related acute promyelocytic leukemia: a report on 16 cases.. Journal of Clinical Oncology. 10(9). 1430–1435. 79 indexed citations

20.

Robert, Jacques, Françoise Rigal‐Huguet, J L Harousseau, et al.. (1987). Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patients. Leukemia Research. 11(11). 961–964. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact